Massive perivillous fibrin deposition
| Massive perivillous fibrin deposition | |
|---|---|
| Synonyms | Maternal floor infarction |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Intrauterine growth restriction, Stillbirth, Recurrent miscarriage |
| Complications | Fetal death, Placental insufficiency |
| Onset | Pregnancy |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly immune-mediated |
| Risks | Previous pregnancy complications, Autoimmune disorders |
| Diagnosis | Histopathology of the placenta |
| Differential diagnosis | Placental abruption, Chorioamnionitis |
| Prevention | None known |
| Treatment | Close monitoring, Aspirin therapy, Heparin therapy |
| Medication | N/A |
| Prognosis | Variable, depends on severity and management |
| Frequency | Rare |
| Deaths | N/A |
Massive Perivillous Fibrin Deposition (MPFD) is a rare placental disorder characterized by the extensive accumulation of fibrin on the chorionic villi of the placenta. This condition is associated with adverse pregnancy outcomes, including fetal growth restriction, stillbirth, and recurrent miscarriage.
Etiology[edit]
The exact cause of MPFD is unknown. However, it is believed to be associated with maternal autoimmune disorders, thrombophilia, and infections. Some studies suggest that MPFD may be a response to maternal-fetal immune conflict.
Pathophysiology[edit]
In MPFD, there is an excessive deposition of fibrin, a protein involved in blood clotting, on the chorionic villi of the placenta. This leads to impaired maternal-fetal circulation, resulting in reduced nutrient and oxygen supply to the fetus. The condition can lead to fetal growth restriction, stillbirth, or recurrent miscarriage.
Diagnosis[edit]
Diagnosis of MPFD is usually made postpartum by histopathological examination of the placenta. Prenatal diagnosis is challenging due to the lack of specific clinical features and imaging findings.
Treatment[edit]
There is no specific treatment for MPFD. Management is usually supportive and aimed at addressing the associated complications. In some cases, anticoagulant therapy may be considered.
Prognosis[edit]
The prognosis of MPFD is generally poor, with a high rate of recurrence in subsequent pregnancies. However, with close monitoring and appropriate management, some women with MPFD may have successful pregnancies.
See also[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


